Dr Reddy's Laboratories has secured market authorization from Health Canada for its generic semaglutide injection. This marks a significant achievement as the first company to receive approval for this diabetes treatment in Canada. The company is now preparing to launch the medication, aiming to provide Canadian patients with access to this important therapy.